ALK-Positive Lung Cancer
2 clinical trials · Condition
◉ Watch ALK-Positive Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC (NCT04087473) | National Cancer Centre, Singapore | 2019-08-23 |
Track ALK-Positive Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.